177 related articles for article (PubMed ID: 32593652)
1. Silence of lncRNA MIAT-mediated inhibition of DLG3 promoter methylation suppresses breast cancer progression via the Hippo signaling pathway.
Li D; Hu X; Yu S; Deng S; Yan M; Sun F; Song J; Tang L
Cell Signal; 2020 Sep; 73():109697. PubMed ID: 32593652
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.
Li S; Hu J; Li G; Mai H; Gao Y; Liang B; Wu H; Guo J; Duan Y
Cell Biol Toxicol; 2023 Aug; 39(4):1359-1375. PubMed ID: 36241925
[TBL] [Abstract][Full Text] [Related]
3. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells.
Li Y; Jiang B; Wu X; Huang Q; Chen W; Zhu H; Qu X; Xie L; Ma X; Huang G
Biochem Biophys Res Commun; 2018 Sep; 503(1):45-50. PubMed ID: 29792859
[TBL] [Abstract][Full Text] [Related]
5. Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway.
Wang HB; Wei H; Wang JS; Li L; Chen AY; Li ZG
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):708-723. PubMed ID: 30611858
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.
Peng X; Ji C; Tan L; Lin S; Zhu Y; Long M; Luo D; Li H
J Cell Mol Med; 2020 Jan; 24(1):304-316. PubMed ID: 31657132
[TBL] [Abstract][Full Text] [Related]
7. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
Huang X; Gao Y; Qin J; Lu S
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
[TBL] [Abstract][Full Text] [Related]
8. lncRNA MIAT promotes luminal B breast cancer cell proliferation, migration, and invasion in vitro.
Mi J; Zhang H; Jiang X; Yi Y; Cao W; Song C; Yuan C
J Appl Genet; 2024 May; 65(2):309-319. PubMed ID: 37987972
[TBL] [Abstract][Full Text] [Related]
9. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212.
Wang R; Zhao L; Ji L; Bai L; Wen Q
Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776
[TBL] [Abstract][Full Text] [Related]
10. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MIAT facilitates osteosarcoma progression by regulating mir-128-3p/VEGFC axis.
Zhang C; Xie L; Liang H; Cui Y
IUBMB Life; 2019 Jul; 71(7):845-853. PubMed ID: 30629798
[TBL] [Abstract][Full Text] [Related]
12. ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway.
Lin Y; Li C; Xiong W; Fan L; Pan H; Li Y
Cell Death Dis; 2021 Nov; 12(11):1042. PubMed ID: 34725332
[TBL] [Abstract][Full Text] [Related]
13. LINC00922 regulates epithelial-mesenchymal transition, invasive and migratory capacities in breast cancer through promoting NKD2 methylation.
Wang Y; Dong T; Wang P; Li S; Wu G; Zhou J; Wang Z
Cell Signal; 2021 Jan; 77():109808. PubMed ID: 33045317
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition.
Zhan Y; Tao Q; Meng Q; Zhang R; Lin L; Li X; Zheng L; Zheng J
Commun Biol; 2023 Mar; 6(1):285. PubMed ID: 36934152
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of DLG3 Promoter Upregulates RAC1 and Activates the PI3K/AKT Signaling Pathway to Promote Breast Cancer Progression.
Liu B; Xu Y; Zhang L; Yang X; Chen L; Liu Y
Evid Based Complement Alternat Med; 2021; 2021():8428130. PubMed ID: 34765009
[TBL] [Abstract][Full Text] [Related]
16. Myocardial Infarction Associated Transcript (MIAT): Review of its impact in the tumorigenesis.
Ghafouri-Fard S; Azimi T; Taheri M
Biomed Pharmacother; 2021 Jan; 133():111040. PubMed ID: 33378948
[TBL] [Abstract][Full Text] [Related]
17. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation.
Li N; Zhao Z; Miao F; Cai S; Liu P; Yu Y; Wang B
Cancer Gene Ther; 2021 May; 28(5):471-485. PubMed ID: 33199829
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
19. MIAT lncRNA is overexpressed in breast cancer and its inhibition triggers senescence and G1 arrest in MCF7 cell line.
Alipoor FJ; Asadi MH; Torkzadeh-Mahani M
J Cell Biochem; 2018 Aug; 119(8):6470-6481. PubMed ID: 29345338
[TBL] [Abstract][Full Text] [Related]
20. Catechin relieves hypoxia/reoxygenation-induced myocardial cell apoptosis via down-regulating lncRNA MIAT.
Cong L; Su Y; Wei D; Qian L; Xing D; Pan J; Chen Y; Huang M
J Cell Mol Med; 2020 Feb; 24(3):2356-2368. PubMed ID: 31955523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]